Japan Bioelectric Medicine Market Size, Share & Industry Trends Analysis Report By Type (Implantable Electroceutical Devices, and Non-invasive Electroceutical Devices), By End-use, By Product, By Application, Outlook and Forecast, 2023 - 2030

The Japan Bioelectric Medicine Market size is expected to reach $1.5 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period.

The bioelectric medicine market in Japan is witnessing a transformative evolution, driven by a convergence of cutting-edge technology, robust healthcare infrastructure, and a commitment to advancing patient-centric care. With a unique blend of traditional medical expertise and technological innovation, Japan's bioelectric medicine landscape reflects a dynamic and progressive environment.

At the industry's core are neuromodulation therapies, where precision and customization are key focal points. Advanced neurostimulation devices, including spinal cord stimulators and deep brain stimulators, are gaining prominence with refinements in electrode design and programming capabilities. These technological advancements enable more targeted interventions, offering effective solutions for chronic pain, neurological disorders, and psychiatric conditions. Japan's commitment to technological excellence is evident in the continuous refinement of neuromodulation therapies, ensuring patients receive personalized and optimized treatments.

Within Japan's bioelectric medicine market, the rise of technological innovations is intricately linked to a cultural ethos that values technological excellence and continuous improvement. As the industry advances, bioelectric interventions are increasingly personalized and tailored to address the physiological aspects of healthcare and individuals' unique needs and preferences. The integration of technological advancements fosters a healthcare landscape in Japan that is more interconnected, precise, and responsive to the dynamic healthcare needs of the population.

Market Trends

Rise in the medical devices industry

The expansion of the medical devices industry in the bioelectric medicine market in Japan is driven by a convergence of several key factors. One of the primary catalysts is Japan's rapidly aging population, characterized by an increasing prevalence of chronic diseases and age-related conditions. As the demand for effective and non-invasive treatments rises, bioelectric medicine emerges as a promising solution for addressing ailments such as chronic pain and neurological disorders commonly associated with aging. The regulatory environment plays a crucial role in shaping the trajectory of the medical devices industry. Japan maintains a robust and well-established regulatory framework, ensuring the safety and efficacy of medical devices in the industry. A transparent and predictable regulatory environment instills confidence among manufacturers and investors, facilitating the timely introduction of new and innovative medical devices into the Japanese industry.

Technological innovation stands out as another pivotal factor propelling the expansion of the medical devices sector in Japan. The country has a longstanding reputation for technological prowess, which extends to medical technology advancements. Ongoing research and development efforts foster the creation of state-of-the-art medical devices, ranging from diagnostic equipment to therapeutic tools, thereby elevating the overall healthcare quality in Japan. Hence, the intersection of Japan's aging population, stringent regulatory standards, and a culture of technological innovation underscores a profound shift in the bioelectric medicine market. This synergy addresses healthcare challenges associated with aging and positions Japan as a global leader in fostering advanced medical devices for improved patient outcomes.

According to the International Trade Administration, Japan's medical devices industry continues to be among the largest in the world. According to the latest official figures from the Ministry of Health Labour and Welfare (MHLW) Annual Pharmaceutical Production Statistics, the Japanese medical devices industry and materials in 2020 was approximately USD 26 billion (USD 1 = Yen 106.8). The industry remains heavily dependent on imports, especially sophisticated medical devices. The demand for advanced medical technologies is expected to increase since Japan has a fast-aging demographic profile, with relatively prosperous seniors holding increasing expectations for improved quality of life in their later years.

Increasing proportion of neurological disorders

The rise in neurological disorders has emerged as a significant catalyst for the growth of the bioelectric medicine market in Japan. As the population ages, there is a discernible increase in the incidence of neurological conditions, including but not limited to neurodegenerative diseases like Alzheimer's and Parkinson's, as well as chronic pain disorders. This demographic shift has created a pressing need for innovative and effective therapeutic solutions, driving the demand for bioelectric medicine that offers targeted and non-invasive interventions for neurological disorders. The emphasis on specificity in addressing the challenges posed by neurological conditions positions bioelectric medicine as a valuable and cutting-edge component within the broader healthcare industry in Japan.

Bioelectric medicine has emerged as a promising frontier in managing and treating various neurological conditions in Japan. With a focus on leveraging electrical impulses to modulate neural activity, this innovative technology holds considerable potential for providing precise and personalized treatments tailored to the unique characteristics of Japanese patients. The Japanese healthcare system's commitment to technological advancements and patient-centric care further supports the integration of bioelectric medicine, paving the way for advancements in neurological treatment protocols that align with the specific healthcare needs of the Japanese population.

In Japan, the number of people with dementia has been increasing due to the expansion of the senior population. The estimation from the National Center for Geriatrics and Gerontology of Japan shows that about 7 million people will suffer from dementia in the year 2025. Therefore, with its precision in addressing unique healthcare needs, bioelectric medicine is a pivotal and forward-looking component within the country's evolving healthcare industry.

Competition Analysis

Japanese companies like JCR Pharmaceuticals and Kaneka Corporation actively participate in the competitive landscape, adding a local perspective to the global industry. With its squalene-based adjuvant, JCR Pharmaceuticals demonstrates promising results in preclinical and clinical studies, contributing to the development of adjuvanted vaccines. Kaneka Corporation, a diversified technology company, explores adjuvant technologies to complement vaccine development efforts, showcasing the country's commitment to bioelectric medicine innovation.

Japan's bioelectric medicine market is enriched by diverse local companies contributing to the burgeoning field of innovative healthcare technologies. Terumo Corporation is a major player, leveraging its global presence in the medical device industry. Headquartered in Tokyo, Terumo specializes in cardiovascular and neurovascular devices, making significant strides in advancing bioelectric medicine. The company's expertise encompasses various medical technologies, positioning it at the forefront of developing cutting-edge solutions that integrate electronics with medical interventions.

Nihon Kohden Corporation, which specializes in medical electronic equipment, is a key contributor to the bioelectric medicine market in Japan. The company's focus on producing devices for monitoring, diagnostic, and treatment purposes, including EEG and EMG equipment, underscores its commitment to advancing the field. Similarly, Fujifilm Corporation, synonymous with imaging and photography, has diversified its portfolio to include healthcare solutions. In the bioelectric medicine market in Japan, Fujifilm's medical division is instrumental in developing diagnostic imaging systems and medical informatics technologies. The companies' contributions extend to developing technologies that facilitate precise and real-time monitoring of physiological parameters, enhancing the efficacy of bioelectric interventions.

List of Key Companies Profiled

• Medtronic PLC
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• Koninklijke Philips N.V.
• Biotronik SE & Co. KG
• Sonova Holding AG
• Nevro Corporation
• electroCore, Inc.

Japan Bioelectric Medicine Market Report Segmentation

By Type

• Implantable Electroceutical Devices
• Non-invasive Electroceutical Devices

By End-use

• Hospitals
• Others

By Product

• Implantable Cardioverter Defibrillators & Cardiac Pacemakers
• Spinal Cord Stimulators
• Cochlear Implants
• Deep Brain Stimulators
• Transcutaneous Electrical Nerve Stimulators
• Sacral & Vagus Nerve Stimulators
• Others

By Application

• Arrhythmia
• Pain Management
• Sensorineural Hearing Loss
• Tremor & Epilepsy
• Parkinson’s Disease
• Depression
• Treatment-resistant Depression
• Urinary & Fecal Incontinence
• Others

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Japan Bioelectric Medicine Market, by Type
1.4.2 Japan Bioelectric Medicine Market, by End-use
1.4.3 Japan Bioelectric Medicine Market, by Product
1.4.4 Japan Bioelectric Medicine Market, by Application
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, May – 2021, Nov) Leading Players
3.4 Porter’s Five Force Analysis

Chapter 4. Japan Bioelectric Medicine Market
4.1 Japan Bioelectric Medicine Market by Type
4.2 Japan Bioelectric Medicine Market by End-use
4.3 Japan Bioelectric Medicine Market by Product
4.4 Japan Bioelectric Medicine Market by Application

Chapter 5. Company Profiles – Global Leaders
5.1 Medtronic PLC
5.1.1 Company overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Research & Development Expenses
5.1.5 Recent strategies and developments:
5.1.5.1 Partnerships, Collaborations, and Agreements:
5.1.5.2 Product Launches and Product Expansions:
5.1.5.3 Acquisition and Mergers:
5.1.5.4 Trials:
5.1.6 SWOT Analysis
5.2 Abbott Laboratories
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expense
5.2.5 Recent strategies and developments:
5.2.5.1 Partnerships, Collaborations, and Agreements:
5.2.5.2 Product Launches and Product Expansions:
5.2.5.3 Approvals:
5.2.6 SWOT Analysis
5.3 Boston Scientific Corporation
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Research & Development Expense
5.3.5 Recent strategies and developments:
5.3.5.1 Product Launches and Product Expansions:
5.3.5.2 Acquisition and Mergers:
5.3.6 SWOT Analysis
5.4 Cochlear Ltd.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Product Launches and Product Expansions:
5.4.5.2 Geographical Expansions:
5.4.6 SWOT Analysis
5.5 LivaNova PLC
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expense
5.5.5 SWOT Analysis
5.6 Koninklijke Philips N.V.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.6.5 Recent strategies and developments:
5.6.5.1 Acquisition and Mergers:
5.6.6 SWOT Analysis
5.7 Biotronik SE & Co. KG
5.7.1 Company Overview
5.7.2 SWOT Analysis
5.8 Sonova Holding AG
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental and Regional Analysis
5.8.4 Research & Development Expenses
5.8.5 Recent strategies and developments:
5.8.5.1 Geographical Expansions:
5.8.6 SWOT Analysis
5.9 Nevro Corporation
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Approvals:
5.9.6 SWOT Analysis
5.10. electroCore, Inc.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Regional Analysis
5.10.4 Research & Development Expenses
5.10.5 Recent strategies and developments:
5.10.5.1 Partnerships, Collaborations, and Agreements:
5.10.5.2 Product Launches and Product Expansions:
5.10.6 SWOT Analysis

TABLE 1 Japan Bioelectric Medicine Market, 2019 - 2022, USD Million
TABLE 2 Japan Bioelectric Medicine Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Bioelectric Medicine Market
TABLE 4 Product Launches And Product Expansions– Bioelectric Medicine Market
TABLE 5 Acquisition and Mergers– Bioelectric Medicine Market
TABLE 6 Geographical Expansions– Bioelectric Medicine Market
TABLE 7 Approvals and trials: Bioelectric Medicine Market
TABLE 8 Japan Bioelectric Medicine Market by Type, 2019 - 2022, USD Million
TABLE 9 Japan Bioelectric Medicine Market by Type, 2023 - 2030, USD Million
TABLE 10 Japan Bioelectric Medicine Market by End-use, 2019 - 2022, USD Million
TABLE 11 Japan Bioelectric Medicine Market by End-use, 2023 - 2030, USD Million
TABLE 12 Japan Bioelectric Medicine Market by Product, 2019 - 2022, USD Million
TABLE 13 Japan Bioelectric Medicine Market by Product, 2023 - 2030, USD Million
TABLE 14 Japan Bioelectric Medicine Market by Application, 2019 - 2022, USD Million
TABLE 15 Japan Bioelectric Medicine Market by Application, 2023 - 2030, USD Million
TABLE 16 Key Information – Medtronic PLC
TABLE 17 Key Information – Abbott Laboratories
TABLE 18 Key Information – Boston Scientific Corporation
TABLE 19 key Information – Cochlear Ltd.
TABLE 20 Key Information – LivaNova PLC
TABLE 21 Key Information – Koninklijke Philips N.V.
TABLE 22 Key Information – Biotronik SE & Co. KG
TABLE 23 key Information – Sonova Holding AG
TABLE 24 Key Information – Nevro Corporation
TABLE 25 Key Information – electroCore, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Japan Bioelectric Medicine Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Bioelectric Medicine Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, May – 2021, Nov) Leading Players
FIG 7 Porter’s Five Force Analysis: Bioelectric Medicine Market
FIG 8 Japan Bioelectric Medicine Market Share by Type, 2022
FIG 9 Japan Bioelectric Medicine Market Share by Type, 2030
FIG 10 Japan Bioelectric Medicine Market by Type, 2019 - 2030, USD Million
FIG 11 Japan Bioelectric Medicine Market Share by End-use, 2022
FIG 12 Japan Bioelectric Medicine Market Share by End-use, 2030
FIG 13 Japan Bioelectric Medicine Market by End-use, 2019 - 2030, USD Million
FIG 14 Japan Bioelectric Medicine Market Share by Product, 2022
FIG 15 Japan Bioelectric Medicine Market Share by Product, 2030
FIG 16 Japan Bioelectric Medicine Market by Product, 2019 - 2030, USD Million
FIG 17 Japan Bioelectric Medicine Market Share by Application, 2022
FIG 18 Japan Bioelectric Medicine Market Share by Application, 2030
FIG 19 Japan Bioelectric Medicine Market by Application, 2019 - 2030, USD Million
FIG 20 Recent strategies and developments: Medtronic PLC
FIG 21 SWOT Analysis: Medtronic PLC
FIG 22 Recent strategies and developments: Abbott Laboratories
FIG 23 SWOT Analysis: Abbott Laboratories
FIG 24 Recent strategies and developments: Boston Scientific Corporation
FIG 25 SWOT Analysis: Boston Scientific Corporation
FIG 26 Recent strategies and developments: Cochlear Ltd.
FIG 27 SWOT Analysis: Cochlear Ltd.
FIG 28 SWOT Analysis: LivaNova PLC
FIG 29 SWOT Analysis: Koninklijke Philips N.V.
FIG 30 SWOT Analysis: Biotronik SE & Co. KG
FIG 31 SWOT Analysis: Sonova Holding AG
FIG 32 SWOT Analysis: NEVRO CORPORATION
FIG 33 Recent strategies and developments: electroCore, Inc.
FIG 34 SWOT Analysis: electroCore, Inc.